Vote Scores
Filings read through

Intellia Therapeutics, Inc.: how funds voted at the meeting of 11 Jun 2025

Ticker
NTLA
Meeting
Season
year to 30 June 2025
Filers reporting
394
Ballot items
5

394 filers on Form N-PX reported votes at the Intellia Therapeutics, Inc. meeting of 11 Jun 2025. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Intellia Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 77.6% of the reported votes are for. 50 filers withheld from or voted against at least one nominee.

    582 vote records from 99 filers. 7 of the 99 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 34
    • Against 3
    • Against management 3
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    535 vote records from 386 filers. 232 of the 363 filers that marked the item voted against management. 23 filers gave no management mark.

    • Positions of 45 fund families
    • For 12
    • Against 33
    • Against management 33
  3. Item 3: Frequency of the say-on-pay vote

    One year: 325 filers. Three years: 12 filers. Abstain: 7 filers. For: 7 filers. Against: 3 filers. None: 2 filers.

    526 vote records from 380 filers. 22 of the 357 filers that marked the item voted against management. 23 filers gave no management mark.

    • Positions of 45 fund families
    • Split or no vote 45
    • Against management 3
  4. Item 4: Audit-related items (auditor ratification)

    194 vote records from 99 filers. 3 of the 99 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 37
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    204 vote records from 103 filers. 46 of the 103 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 16
    • Against 21
    • Against management 21

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Intellia Therapeutics, Inc., meeting of 11 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplitNo report
AllspringAgainst, against managementSplitFor
American BeaconForSplitFor
American CenturyAgainst, against managementSplitFor
BlackRock and iSharesForSplitFor
BNY MellonAgainst, against managementSplitNo report
Brighthouse FundsAgainst, against managementSplitFor
Capital Group and American FundsAgainst, against managementSplitFor
Charles SchwabAgainst, against managementSplitFor
DimensionalAgainst, against managementSplit, against managementFor
DWSAgainst, against managementSplitFor
EquitableForSplitFor
Federated HermesAgainst, against managementSplitFor
FidelityForSplitFor
First TrustAgainst, against managementSplitNo report
Franklin TempletonAgainst, against managementSplitFor
Global XAgainst, against managementSplitFor
Goldman SachsAgainst, against managementSplitFor
Guggenheim and RydexAgainst, against managementSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganForSplitFor
Jackson National fundsAgainst, against managementSplit, against managementFor
John Hancock and ManulifeAgainst, against managementSplitFor
Lincoln FinancialForSplitFor
Macquarie and Delaware FundsAgainst, against managementSplitFor
MassMutualForSplitNo report
Morgan Stanley, Eaton Vance and CalvertForSplitFor
NationwideForSplitFor
Natixis and Loomis SaylesAgainst, against managementSplitNo report
Neuberger BermanAgainst, against managementSplitNo report
Northern Trust and FlexSharesAgainst, against managementSplitFor
Nuveen and TIAAAgainst, against managementSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialAgainst, against managementSplit, against managementFor
PrincipalAgainst, against managementSplitNo report
ProShares and ProFundsAgainst, against managementSplitFor
Russell InvestmentsAgainst, against managementSplitNo report
SEIAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceAgainst, against managementSplitFor
ThriventAgainst, against managementSplitFor
VanguardForSplitFor
Victory CapitalAgainst, against managementSplitFor
VoyaAgainst, against managementSplitFor
WisdomTreeAgainst, against managementSplitFor

Questions

How many filers reported votes at the Intellia Therapeutics, Inc. meeting?
394 Form N-PX filers reported votes at the meeting of 11 Jun 2025. On say-on-pay, 232 of 363 filers that marked the item voted against management (63.9%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Intellia Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Intellia Therapeutics, Inc. with a meeting date within three days of 11 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .